Contract Small Molecule API Manufacturing Industry by the Numbers

This report is an updated version of the 2019 edition and characterizes the contract small molecule active pharmaceutical ingredient (API) manufacturing industry through a number of quantitative dimensions, including number and type of participants, containment and controlled substance capabilities, and financial performance of the top public contract manufacturing organizations (CMOs). Contract Small Molecule API Manufacturing is critical for establishing an understanding of the small molecule API CMO industry and the features of some of the largest CMOs participating in the industry.

Scope

This 53-page report gives important, expert insight you won’t find in any other source. 31 tables and figures throughout the report illustrate major points and trends. This report is required reading for:
CMO executives who must have deep understanding of the small molecule API marketplace to make strategic planning and investment decisions.
Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

Overview of contract small molecule API facilities and the proportion of containment and controlled substance specialist capabilities
Detailed view of the geographic distribution of small molecule API facilities
Establishing which CMOs are most involved in contract small molecule API industry by facility count
Analysis of M&A activity related to small molecule API facilities

1 Executive Summary2 Players3 Trends

4 Industry Analysis

4.1 Industry Size and Structure
4.2 Industry Demographics
4.3 Top CMOs by Small Molecule API Facilities
4.4 Characteristics of the Largest CMOs

5 M&A Activity Involving Small Molecule Contract Manufacturing Facilities6 The Outlook for the API CMO Industry7 Value Chain8 Companies

9 Appendix

9.1 Methodology
9.2 Bibliography
9.3 Primary Research - Key Opinion Leaders
9.4 Further Reading

10 About the Authors

Contact The Publisher

List of Tables

Table 1: Small Molecule API CMO Trends, 2021
Table 2: Revenue Composition and Specialized Capabilities of Leading CMOs, 2020
Table 3: Percentage of Companies by Revenue Tier with Specialized Capabilities (Dedicated Contract Public CMOs Only)
Table 4: CMO Small Molecule API Manufacturing Facility-Only Acquisitions, 2018-2020
Table 5: CMO Small Molecule API Manufacturing Facilities Acquired by Company M&A and Divestment, 2018-2020
Table 6: CMOs With Small Molecule API Manufacturing Facilities Acquired by PE, 2018-2020
Table 7: Geographical Reach of Public Companies in the API CMO Universe, 2021
Table 8: Further Reading

List of Figures

Figure 1: Leading API CMOs, 2021
Figure 2: Top Contract Small Molecule API Trends in the CMO Industry, 2021
Figure 3: Geographic Reach of the Small Molecule API CMO Universe, 2021 (Public CMOs Only)
Figure 4: Public CMOs with Small Molecule Manufacturing Capability by Annual Contract Revenue, 2020
Figure 5: Geographic Distribution by Headquarters of Public Small Molecule API Dedicated Contract CMOs
Figure 6: Top CMOs by Small Molecule API Manufacturing Facilities
Figure 7: Top CMOs by Small Molecule API Manufacturing Facilities, Change Between 2019 and 2021
Figure 8: Top CMOs by Small Molecule API Facilities with Controlled Substance Capabilities
Figure 9: Top CMOs by Small Molecule API Facilities with Containment Capabilities
Figure 10: Top CMOs by Small Molecule API Manufacturing Facilities with Containment Capabilities, Change Between 2019 and 2021
Figure 11: Geographical Distribution of All CMO Small Molecule API Manufacturing Facilities
Figure 12: Geographical Distribution of Controlled Substance Small Molecule Manufacturing Facilities
Figure 13: Geographical Distribution of Small Molecule Manufacturing Facilities with Containment
Figure 14: NMEs Requiring Special Handling, 2011-2020
Figure 15: Geographical Distribution of China’s Small Molecule API CDMO Facilities
Figure 16: Distribution of Chinese Small Molecule Contract Manufacturing Facilities with Containment Capabilities
Figure 17: Distribution of Chinese Small Molecule Contract Manufacturing Facilities with Controlled Substance Capabilities Across Top Three Locations, 2021
Figure 18: Public CMOs with Small Molecule Manufacturing Capability by Accumulated Revenue, 2020
Figure 19: Small Molecule API Containment Facility Acquisitions by Acquiring CMO, 2018-2020
Figure 20: Small Molecule API Controlled Substance Facility Acquisitions by Acquiring CMO, 2018-2020
Figure 21: Small Molecule API Containment Facility Acquisitions by Location, 2018-2020
Figure 22: Small Molecule API Controlled Substance Facility Acquisitions by Location, 2018-2020
Figure 23: The Contract Manufacturing Value Chain

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

- Jetpharma SA
Escientia Life Science LLC
Godavari Drugs Ltd
Chifeng Yingfa Pharmaceutical Co Ltd
Jiangxi Xinganjiang pharmaceutical Co Ltd
Midwest Pharmaceutics NZ Ltd
Aragen Life Sciences Pvt Ltd
Gufic BioSciences Ltd
Microfine Pharma Pvt Ltd
Chemic Laboratories Inc
Hainan Shuangcheng Pharmaceuticals Co Ltd
Arene Lifesciences Pvt Ltd
FOB Synthesis Inc
Jiangxi Aifeimu Technology Co Ltd
Fleming Laboratories Ltd
Alkaloids Corp
Lianyungang Guike Pharmaceutical Co Ltd
A. R. Life Sciences Pvt Ltd
Lianyungang Jinkang Pharmaceutical Technology Co Ltd
Cangzhou Enke Pharma-tech Co Ltd
Hubei Yitai Pharmaceutical Co Ltd
Inga Pharmaceuticals
Pharm-Sintez
Beximco Pharmaceuticals Ltd
Lianyungang Hengfei Pharmaceutical Co Ltd
Antibiotice SA
Accrete Pharmaceuticals Pvt Ltd
Micro-Sphere SA
Farmak AS
Aktinos Pharma Pvt Ltd

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€4869EUR$4,995USD£4,056GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€9737EUR$9,990USD£8,113GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€14606EUR$14,985USD£12,169GBP

Contract Small Molecule API Manufacturing Industry by the Numbers - 2021 Edition

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Scope

Reasons to Buy

Table of Contents

Companies Mentioned (Partial List)

Related Topics

Related Reports

Small Molecule API Global Market Report 2024

Small Molecule API - Global Strategic Business Report

Small Molecule API Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Product Type

Small Molecule Targeted Cancer Therapy Global Market Insights 2024, Analysis and Forecast to 2029, by Market Participants, Regions, Technology

Vascular Endothelial Growth Factor (VEGF) Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)